Logo image of DIM.PA

SARTORIUS STEDIM BIOTECH (DIM.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:DIM - FR0013154002 - Common Stock

209.8 EUR
+5.8 (+2.84%)
Last: 1/22/2026, 1:33:03 PM
Fundamental Rating

4

DIM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 20 industry peers in the Life Sciences Tools & Services industry. While DIM is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, DIM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • DIM had positive earnings in the past year.
  • DIM had a positive operating cash flow in the past year.
  • DIM had positive earnings in each of the past 5 years.
  • In the past 5 years DIM always reported a positive cash flow from operatings.
DIM.PA Yearly Net Income VS EBIT VS OCF VS FCFDIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • DIM has a Return On Assets of 3.36%. This is in the lower half of the industry: DIM underperforms 65.00% of its industry peers.
  • DIM has a worse Return On Equity (6.55%) than 60.00% of its industry peers.
  • DIM has a Return On Invested Capital (5.94%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DIM is in line with the industry average of 9.00%.
  • The last Return On Invested Capital (5.94%) for DIM is well below the 3 year average (10.41%), which needs to be investigated, but indicates that DIM had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.36%
ROE 6.55%
ROIC 5.94%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
DIM.PA Yearly ROA, ROE, ROICDIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • DIM's Profit Margin of 8.98% is in line compared to the rest of the industry. DIM outperforms 55.00% of its industry peers.
  • DIM's Profit Margin has declined in the last couple of years.
  • The Operating Margin of DIM (16.63%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of DIM has declined.
  • With a decent Gross Margin value of 45.64%, DIM is doing good in the industry, outperforming 65.00% of the companies in the same industry.
  • DIM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 16.63%
PM (TTM) 8.98%
GM 45.64%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
DIM.PA Yearly Profit, Operating, Gross MarginsDIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DIM is still creating some value.
  • DIM has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DIM has more shares outstanding
  • The debt/assets ratio for DIM has been reduced compared to a year ago.
DIM.PA Yearly Shares OutstandingDIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DIM.PA Yearly Total Debt VS Total AssetsDIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • DIM has an Altman-Z score of 4.40. This indicates that DIM is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.40, DIM is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • DIM has a debt to FCF ratio of 6.84. This is a slightly negative value and a sign of low solvency as DIM would need 6.84 years to pay back of all of its debts.
  • DIM has a worse Debt to FCF ratio (6.84) than 60.00% of its industry peers.
  • A Debt/Equity ratio of 0.50 indicates that DIM is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.50, DIM perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.84
Altman-Z 4.4
ROIC/WACC0.64
WACC9.34%
DIM.PA Yearly LT Debt VS Equity VS FCFDIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.05 indicates that DIM should not have too much problems paying its short term obligations.
  • DIM's Current ratio of 1.05 is on the low side compared to the rest of the industry. DIM is outperformed by 70.00% of its industry peers.
  • A Quick Ratio of 0.50 indicates that DIM may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.50, DIM is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.5
DIM.PA Yearly Current Assets VS Current LiabilitesDIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 35.11% over the past year.
  • The Earnings Per Share has been growing slightly by 4.19% on average over the past years.
  • The Revenue has been growing slightly by 7.72% in the past year.
  • Measured over the past years, DIM shows a quite strong growth in Revenue. The Revenue has been growing by 14.05% on average per year.
EPS 1Y (TTM)35.11%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%23.68%
Revenue 1Y (TTM)7.72%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%7.67%

3.2 Future

  • DIM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.17% yearly.
  • DIM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.86% yearly.
EPS Next Y29.39%
EPS Next 2Y23.86%
EPS Next 3Y23.06%
EPS Next 5Y21.17%
Revenue Next Year7.45%
Revenue Next 2Y8.04%
Revenue Next 3Y9.07%
Revenue Next 5Y9.86%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DIM.PA Yearly Revenue VS EstimatesDIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
DIM.PA Yearly EPS VS EstimatesDIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 48.68, which means the current valuation is very expensive for DIM.
  • Based on the Price/Earnings ratio, DIM is valued more expensive than 80.00% of the companies in the same industry.
  • DIM is valuated expensively when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 39.07, the valuation of DIM can be described as expensive.
  • Based on the Price/Forward Earnings ratio, DIM is valued more expensive than 80.00% of the companies in the same industry.
  • DIM's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.30.
Industry RankSector Rank
PE 48.68
Fwd PE 39.07
DIM.PA Price Earnings VS Forward Price EarningsDIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DIM indicates a rather expensive valuation: DIM more expensive than 85.00% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, DIM is valued a bit more expensive than the industry average as 65.00% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 54.51
EV/EBITDA 27.37
DIM.PA Per share dataDIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • DIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as DIM's earnings are expected to grow with 23.06% in the coming years.
PEG (NY)1.66
PEG (5Y)11.61
EPS Next 2Y23.86%
EPS Next 3Y23.06%

More info and screens

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.32%, DIM is not a good candidate for dividend investing.
  • DIM's Dividend Yield is slightly below the industry average, which is at 0.54.
  • With a Dividend Yield of 0.32, DIM pays less dividend than the S&P500 average, which is at 1.86.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

  • The dividend of DIM has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
DIM.PA Yearly Dividends per shareDIM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

  • 25.37% of the earnings are spent on dividend by DIM. This is a low number and sustainable payout ratio.
  • DIM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP25.37%
EPS Next 2Y23.86%
EPS Next 3Y23.06%
DIM.PA Yearly Income VS Free CF VS DividendDIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DIM.PA Dividend Payout.DIM.PA Dividend Payout, showing the Payout Ratio.DIM.PA Dividend Payout.PayoutRetained Earnings

More info and screens

SARTORIUS STEDIM BIOTECH

EPA:DIM (1/22/2026, 1:33:03 PM)

209.8

+5.8 (+2.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-16
Earnings (Next)02-16
Inst Owners11.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.42B
Revenue(TTM)2.95B
Net Income(TTM)264.50M
Analysts81.11
Price Target247.31 (17.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP25.37%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.99%
Min EPS beat(2)-2.24%
Max EPS beat(2)10.22%
EPS beat(4)3
Avg EPS beat(4)9.45%
Min EPS beat(4)-2.24%
Max EPS beat(4)22.18%
EPS beat(8)3
Avg EPS beat(8)-1.58%
EPS beat(12)3
Avg EPS beat(12)-11.08%
EPS beat(16)4
Avg EPS beat(16)-13.1%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-3.94%
Max Revenue beat(2)0.3%
Revenue beat(4)3
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-3.94%
Max Revenue beat(4)3.52%
Revenue beat(8)5
Avg Revenue beat(8)-0.23%
Revenue beat(12)5
Avg Revenue beat(12)-1.54%
Revenue beat(16)7
Avg Revenue beat(16)-0.72%
PT rev (1m)2.7%
PT rev (3m)3.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.67%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)1.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.67%
Revenue NY rev (1m)-1.45%
Revenue NY rev (3m)-1.45%
Valuation
Industry RankSector Rank
PE 48.68
Fwd PE 39.07
P/S 6.93
P/FCF 54.51
P/OCF 27.95
P/B 5.06
P/tB N/A
EV/EBITDA 27.37
EPS(TTM)4.31
EY2.05%
EPS(NY)5.37
Fwd EY2.56%
FCF(TTM)3.85
FCFY1.83%
OCF(TTM)7.51
OCFY3.58%
SpS30.27
BVpS41.47
TBVpS-4.02
PEG (NY)1.66
PEG (5Y)11.61
Graham Number63.42
Profitability
Industry RankSector Rank
ROA 3.36%
ROE 6.55%
ROCE 7.46%
ROIC 5.94%
ROICexc 6.26%
ROICexgc 21.64%
OM 16.63%
PM (TTM) 8.98%
GM 45.64%
FCFM 12.71%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexgc growth 3Y-36.77%
ROICexgc growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.84
Debt/EBITDA 2.5
Cap/Depr 112.98%
Cap/Sales 12.09%
Interest Coverage 3.09
Cash Conversion 90.75%
Profit Quality 141.63%
Current Ratio 1.05
Quick Ratio 0.5
Altman-Z 4.4
F-Score8
WACC9.34%
ROIC/WACC0.64
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)35.11%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%23.68%
EPS Next Y29.39%
EPS Next 2Y23.86%
EPS Next 3Y23.06%
EPS Next 5Y21.17%
Revenue 1Y (TTM)7.72%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%7.67%
Revenue Next Year7.45%
Revenue Next 2Y8.04%
Revenue Next 3Y9.07%
Revenue Next 5Y9.86%
EBIT growth 1Y25.48%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year93.64%
EBIT Next 3Y36.06%
EBIT Next 5Y27.25%
FCF growth 1Y219.35%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y15.98%
OCF growth 3Y5.11%
OCF growth 5Y21.32%

SARTORIUS STEDIM BIOTECH / DIM.PA FAQ

What is the fundamental rating for DIM stock?

ChartMill assigns a fundamental rating of 4 / 10 to DIM.PA.


What is the valuation status of SARTORIUS STEDIM BIOTECH (DIM.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS STEDIM BIOTECH (DIM.PA). This can be considered as Overvalued.


What is the profitability of DIM stock?

SARTORIUS STEDIM BIOTECH (DIM.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of SARTORIUS STEDIM BIOTECH (DIM.PA) stock?

The Price/Earnings (PE) ratio for SARTORIUS STEDIM BIOTECH (DIM.PA) is 48.68 and the Price/Book (PB) ratio is 5.06.


What is the earnings growth outlook for SARTORIUS STEDIM BIOTECH?

The Earnings per Share (EPS) of SARTORIUS STEDIM BIOTECH (DIM.PA) is expected to grow by 29.39% in the next year.